
Quarterly ResultMay 11, 2026, 05:17 PM
U.S. Physical Therapy Q1 Revenue $198M, Net Income $5.0M; Reaffirms FY26 EBITDA
AI Summary
U.S. Physical Therapy reported Q1 2026 total revenue of $198 million, a 7.9% increase year-over-year, with physical therapy revenue up 7.2% and industrial injury prevention revenue up 11.8%. Net income attributable to shareholders decreased to $5.0 million from $9.9 million in Q1 2025, and GAAP loss per share was $0.12, impacted by a loss on contingent earn-out considerations and re-evaluation of redeemable non-controlling interest. The company reaffirmed its full-year 2026 adjusted EBITDA guidance of $102 million to $106 million, citing confidence from ongoing initiatives and strong demand despite a $3-4 million revenue impact from Q1 weather.
Key Highlights
- Total revenue increased 7.9% to $198 million for Q1 2026.
- Net income attributable to shareholders was $5.0 million, down from $9.9 million in Q1 2025.
- Adjusted EBITDA rose to $20.2 million, a $0.7 million increase compared to Q1 2025.
- Acquired a 50% interest in an eight-clinic PT practice and a 70% interest in an IIP business.
- Repurchased $14 million in equity from two strong partnerships.
- Renegotiated a 5-year, $450 million credit facility with improved pricing and terms.
- Reaffirmed full-year 2026 adjusted EBITDA guidance of $102 million to $106 million.
- Total patient visits increased 6.9% to 1,543,000, with net patient revenue per visit at $106.49.
Price Impact
More from USPH